Skip to Content

G I-150 (Ibandronate Sodium 150 mg (base))

Pill with imprint G I-150 is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Mylan Pharmaceuticals Inc..

Ibandronate is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for G I-150

Ibandronate sodium 150 mg (base) G I-150

Ibandronate Sodium

Imprint:
G I-150
Strength:
150 mg (base)
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
ammonia
ferrosoferric oxide
silicon dioxide
crospovidone
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
shellac
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide